STOCK TITAN

Uniqure Financials

QURE
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Uniqure (QURE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI QURE FY2025

uniQure remains a capital-funded R&D enterprise, with customer revenue too small to absorb its recurring operating burn.

The move from negative equity in FY2024 to positive equity in FY2025 looks more like a recapitalization than a self-funded recovery, because the balance sheet improved while the core business kept consuming cash. Shares outstanding rose 27.3% and financing supplied $415.4M, even though operating cash flow stayed deeply negative and revenue remained small.

Revenue of $16.1M covered only a small fraction of $140.7M of R&D in FY2025, continuing the post-FY2021 reset in which the cost base stayed research-heavy after revenue fell back. That makes this financially a development-stage platform: customer inflows exist, but they are not yet the mechanism paying for the science.

The cash burn is operating-driven, not capex-driven: operating cash outflow of -$178.0M nearly matched free cash flow of -$178.4M. With capital spending only $439K and a current ratio of 10.4x, year-end cash of $80.2M still covered less than half of that annual burn, so financing access mattered more than near-term payables.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&D Intensity Revenue Progress Burn Trend Balance Sheet 45 / 100
Financial Health Score 45/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Uniqure's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
25
Dilution
43
R&D Intensity
91
Revenue Progress
51
Burn Trend
34
Balance Sheet
27
Altman Z-Score Distress
0.82

Uniqure scores 0.82, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($3.1B) relative to total liabilities ($626.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
4/9

Uniqure passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality
0.89x

For every $1 of reported earnings, Uniqure generates $0.89 in operating cash flow (-$178.0M OCF vs -$199.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-3.0x

Uniqure earns $-3.0 in operating income for every $1 of interest expense (-$185.3M vs $62.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$16.1M
YoY-40.6%
5Y CAGR-15.6%
10Y CAGR+4.3%

Uniqure generated $16.1M in revenue in fiscal year 2025. This represents a decrease of 40.6% from the prior year.

EBITDA
-$170.6M
YoY+0.6%

Uniqure's EBITDA was -$170.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 0.6% from the prior year.

Net Income
-$199.0M
YoY+16.9%

Uniqure reported -$199.0M in net income in fiscal year 2025. This represents an increase of 16.9% from the prior year.

EPS (Diluted)
$-3.46
YoY+29.7%

Uniqure earned $-3.46 per diluted share (EPS) in fiscal year 2025. This represents an increase of 29.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$178.4M
YoY+4.1%

Uniqure generated -$178.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 4.1% from the prior year.

Cash & Debt
$80.2M
YoY-49.5%
5Y CAGR-20.0%
10Y CAGR-9.7%

Uniqure held $80.2M in cash against $49.7M in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
62M
YoY+27.2%
5Y CAGR+6.8%
10Y CAGR+9.9%

Uniqure had 62M shares outstanding in fiscal year 2025. This represents an increase of 27.2% from the prior year.

Margins & Returns

Gross Margin
89.5%
YoY-5.8pp
5Y CAGR-2.7pp

Uniqure's gross margin was 89.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 5.8 percentage points from the prior year.

Operating Margin
-1151.4%
YoY-471.8pp
5Y CAGR-817.0pp
10Y CAGR-478.7pp

Uniqure's operating margin was -1151.4% in fiscal year 2025, reflecting core business profitability. This is down 471.8 percentage points from the prior year.

Net Margin
-1236.2%
YoY-352.7pp
5Y CAGR-902.9pp
10Y CAGR-460.2pp

Uniqure's net profit margin was -1236.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 352.7 percentage points from the prior year.

Return on Equity
-100.0%
5Y CAGR-48.8pp
10Y CAGR-35.9pp

Uniqure's ROE was -100.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending
$140.7M
YoY-2.2%
5Y CAGR+2.8%
10Y CAGR+9.1%

Uniqure invested $140.7M in research and development in fiscal year 2025. This represents a decrease of 2.2% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$439K
YoY-87.0%
5Y CAGR-43.0%
10Y CAGR-24.8%

Uniqure invested $439K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 87.0% from the prior year.

QURE Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $3.6M-36.0% $5.6M+50.4% $3.7M-29.7% $5.3M+235.8% $1.6M-70.0% $5.2M+128.3% $2.3M-79.4% $11.1M
Cost of Revenue $219K-49.7% $435K+9.3% $398K-39.3% $656K+233.0% $197K-68.2% $619K+134.5% $264K+12.8% $234K
Gross Profit $3.3M-34.9% $5.1M+55.4% $3.3M-28.3% $4.6M+236.2% $1.4M-70.2% $4.6M+127.5% $2.0M-81.4% $10.9M
R&D Expenses $29.2M-16.1% $34.8M+1.2% $34.4M-2.9% $35.4M-2.1% $36.1M-7.0% $38.8M+26.9% $30.6M-9.1% $33.7M
SG&A Expenses $20.1M-7.1% $21.6M+11.2% $19.4M+44.0% $13.5M+23.8% $10.9M-4.1% $11.4M-1.7% $11.6M-26.6% $15.8M
Operating Income -$45.7M+10.6% -$51.1M-0.2% -$51.0M-16.3% -$43.9M-11.5% -$39.3M+14.2% -$45.8M-13.9% -$40.2M+8.6% -$44.0M
Interest Expense $14.0M-3.7% $14.6M-12.8% $16.7M+7.2% $15.6M+3.2% $15.1M+1.6% $14.9M-10.4% $16.6M+2.8% $16.2M
Income Tax $488K+112.5% -$3.9M-145.4% $8.6M+1929.6% $425K-14.3% $496K-42.1% $856K+2861.3% -$31K-103.3% $948K
Net Income -$53.5M-44.2% -$37.1M+53.9% -$80.5M-113.5% -$37.7M+13.6% -$43.6M+40.5% -$73.3M-65.2% -$44.4M+21.2% -$56.3M
EPS (Diluted) $-0.85 N/A $-1.38-100.0% $-0.69+15.9% $-0.82 N/A $-0.91+21.6% $-1.16

QURE Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $778.7M-5.6% $824.9M-7.1% $888.4M+51.9% $584.9M-3.4% $605.4M+8.8% $556.5M-13.8% $645.8M-11.6% $730.8M
Current Assets $615.7M-6.1% $656.0M-8.4% $716.2M+75.3% $408.6M-6.2% $435.4M+11.6% $390.3M-15.9% $464.1M-21.6% $592.0M
Cash & Equivalents $140.0M+74.5% $80.2M-86.6% $597.1M+135.3% $253.8M+16.8% $217.2M+36.7% $158.9M-36.8% $251.6M-12.6% $287.9M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $3.6M-39.2% $5.9M N/A N/A N/A N/A N/A N/A
Goodwill $24.8M-2.1% $25.4M+0.1% $25.3M-0.1% $25.3M+8.5% $23.4M+4.2% $22.4M-6.9% $24.1M+4.2% $23.1M
Total Liabilities $629.4M+0.5% $626.0M-5.1% $659.6M+12.0% $588.9M+3.0% $571.7M+1.5% $563.3M-4.5% $590.0M-6.9% $633.7M
Current Liabilities $59.2M-5.9% $62.9M-37.5% $100.6M+145.9% $40.9M+12.7% $36.3M-9.3% $40.1M-43.8% $71.3M-11.4% $80.5M
Long-Term Debt $49.9M+0.5% $49.7M-4.2% $51.9M+0.1% $51.8M+0.5% $51.6M+0.5% $51.3M+0.4% $51.1M-50.1% $102.5M
Total Equity $149.3M-24.9% $198.9M-13.0% $228.7M+5814.4% -$4.0M-111.9% $33.7M+598.9% -$6.8M-112.1% $55.8M-42.5% $97.1M
Retained Earnings -$1.4B-4.0% -$1.3B-2.9% -$1.3B-6.6% -$1.2B-3.2% -$1.2B-3.9% -$1.1B-6.9% -$1.1B-4.4% -$1.0B

QURE Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$38.2M+50.7% -$77.6M-373.0% -$16.4M+58.9% -$39.9M+9.5% -$44.1M+16.5% -$52.8M-44.4% -$36.6M-11.9% -$32.7M
Capital Expenditures $140K+17.6% $119K+280.3% -$66K-125.4% $260K+106.3% $126K+215.0% $40K-89.5% $380K-37.1% $604K
Free Cash Flow -$38.4M+50.6% -$77.7M-371.8% -$16.5M+59.0% -$40.2M+9.2% -$44.2M+16.4% -$52.9M-43.0% -$37.0M-11.0% -$33.3M
Investing Cash Flow $98.6M+122.3% -$441.4M-1760.6% $26.6M-63.6% $73.1M+263.6% $20.1M+175.5% -$26.6M-155.9% $47.7M-38.8% $77.9M
Financing Cash Flow $550K-77.5% $2.4M-99.3% $332.2M+754979.5% $44K-99.9% $80.7M+1337.8% -$6.5M+87.7% -$53.0M N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

QURE Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 93.8%+1.7pp 92.2%+2.9pp 89.3%+1.7pp 87.5%+0.1pp 87.4%-0.7pp 88.1%-0.3pp 88.5%-9.4pp 97.9%
Operating Margin -1283.5%-365.5pp -918.1%+460.9pp -1379.0%-545.3pp -833.6%+1676.3pp -2510.0%-1632.2pp -877.8%+881.2pp -1759.0%-1363.4pp -395.6%
Net Margin -1503.0%-836.4pp -666.6%+1509.3pp -2175.9%-1459.1pp -716.8%+2067.9pp -2784.8%-1380.7pp -1404.0%+536.4pp -1940.4%-1434.4pp -506.0%
Return on Equity -35.9%-17.2pp -18.7%+16.5pp -35.2% N/A -129.5% N/A -79.5%-21.5pp -58.0%
Return on Assets -6.9%-2.4pp -4.5%+4.6pp -9.1%-2.6pp -6.5%+0.8pp -7.2%+6.0pp -13.2%-6.3pp -6.9%+0.8pp -7.7%
Current Ratio 10.40-0.0 10.43+3.3 7.12-2.9 9.98-2.0 11.99+2.2 9.74+3.2 6.51-0.8 7.36
Debt-to-Equity 0.33+0.1 0.25+0.0 0.23+13.2 -12.95-14.5 1.53+9.1 -7.60-8.5 0.92-0.1 1.06
FCF Margin -1077.6%+317.7pp -1395.3%-950.4pp -444.9%+318.2pp -763.1%+2059.2pp -2822.3%-1809.4pp -1012.9%+604.0pp -1616.9%-1317.5pp -299.4%

Similar Companies

Frequently Asked Questions

Uniqure (QURE) reported $16.1M in total revenue for fiscal year 2025. This represents a -40.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Uniqure (QURE) revenue declined by 40.6% year-over-year, from $27.1M to $16.1M in fiscal year 2025.

No, Uniqure (QURE) reported a net income of -$199.0M in fiscal year 2025, with a net profit margin of -1236.2%.

Uniqure (QURE) reported diluted earnings per share of $-3.46 for fiscal year 2025. This represents a 29.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Uniqure (QURE) had EBITDA of -$170.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Uniqure (QURE) had $80.2M in cash and equivalents against $49.7M in long-term debt.

Uniqure (QURE) had a gross margin of 89.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Uniqure (QURE) had an operating margin of -1151.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Uniqure (QURE) had a net profit margin of -1236.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Uniqure (QURE) has a return on equity of -100.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Uniqure (QURE) generated -$178.4M in free cash flow during fiscal year 2025. This represents a 4.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Uniqure (QURE) generated -$178.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Uniqure (QURE) had $824.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Uniqure (QURE) invested $439K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Uniqure (QURE) invested $140.7M in research and development during fiscal year 2025.

Uniqure (QURE) had 62M shares outstanding as of fiscal year 2025.

Uniqure (QURE) had a current ratio of 10.43 as of fiscal year 2025, which is generally considered healthy.

Uniqure (QURE) had a debt-to-equity ratio of 0.25 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Uniqure (QURE) had a return on assets of -24.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Uniqure (QURE) had $80.2M in cash against an annual operating cash burn of $178.0M. This gives an estimated cash runway of approximately 5 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Uniqure (QURE) has an Altman Z-Score of 0.82, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Uniqure (QURE) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Uniqure (QURE) has an earnings quality ratio of 0.89x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Uniqure (QURE) has an interest coverage ratio of -3.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Uniqure (QURE) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top